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Glucose ingestion after an overnight fast triggers an insulin-dependent, homeostatic program that is
altered in diabetes. The full spectrum of biochemical changes associated with this transition is
currently unknown. We have developed a mass spectrometry-based strategy to simultaneously
measure 191 metabolites following glucose ingestion. In two groups of healthy individuals (n¼22
and 25), 18 plasma metabolites changed reproducibly, including bile acids, urea cycle
intermediates, and purine degradation products, none of which were previously linked to glucose
homeostasis. The metabolite dynamics also revealed insulin’s known actions along four key axes—
proteolysis, lipolysis, ketogenesis, and glycolysis—reflecting a switch from catabolism to
anabolism. In pre-diabetics (n¼25), we observed a blunted response in all four axes that correlated
with insulin resistance. Multivariate analysis revealed that declines in glycerol and leucine/iso-
leucine (markers of lipolysis and proteolysis, respectively) jointly provide the strongest predictor of
insulin sensitivity. This observation indicates that some humans are selectively resistant to insulin’s
suppression of proteolysis, whereas others, to insulin’s suppression of lipolysis. Our findings lay the
groundwork for using metabolic profiling to define an individual’s ‘insulin response profile’, which
could have value in predicting diabetes, its complications, and in guiding therapy.
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Introduction
Glucose homeostasis is a complex physiologic process invol-
ving the orchestration of multiple organ systems. During an
overnight fast, for instance, glucose levels are maintained
through both glycogenolysis and gluconeogenesis, and the
liver begins to generate ketone bodies (e.g. acetoacetate,
b-hydroxybutyrate) from fatty acids released by adipose tissue
(Cahill, 2006). Ingestion of glucose after overnight fasting then
triggers the rapid release of insulin from the pancreas, which
promotes glucose uptake in peripheral tissues and switches
the body from catabolism to anabolism. For example,
proteolysis in skeletal muscle and associated release of amino
acids (which support gluconeogenesis) are replaced by amino-
acid uptake and protein synthesis (Felig, 1975; Fukagawa et al,
1985). Also, triacylglycerol lysis in adipose tissue and hepatic
synthesis of ketone bodies are inhibited and replaced by fatty
acid uptake and re-esterification. Hence the transition from
fasting to feeding is accompanied by many changes in
metabolite concentrations as the body makes adjustments to
achieve glucose homeostasis.
To obtain a systematic view of the physiologic response to
glucose ingestion in health and disease, we wished to
simultaneously monitor the concentrations of a large and
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diverse set of metabolites. Such an integrated analysis can aid
in the classification of metabolic states, reveal new pathways,
and potentially improve the sensitivity for detection of
abnormalities. Traditionally, single metabolites or classes
of small molecules have been detected using dedicated
analytical assays. With these methods, relationships among
diverse metabolites and pathways have been missed, and a
comprehensive picture of a complex physiologic program has
not been possible. Such relationships could, in principle, be
important in understanding disease pathogenesis and in aiding
in the diagnosis of disease.
Recent advances in analytical chemistry and computation
now enable the simultaneous measurement of a large number
of metabolites. Two technologies are commonly used for
metabolic profiling: nuclear magnetic resonance (NMR)
spectroscopy and mass spectrometry (MS) (Dunn et al,
2005). Although NMR spectroscopy has a number of advan-
tages, primarily its non-destructive nature, its ability to
provide information on chemical structure and its better
suitability for absolute quantification, it tends to have low
sensitivity. MS technology, on the other hand, affords sensitive
and specific analysis of metabolites in complex biological
samples, particularly when implemented as tandem MS and
coupled with high-performance liquid chromatography (LC), a
combination termed LC-MS/MS. Metabolic profiling with LC-
MS/MS technology has already been successfully used for
identifying human plasma markers of myocardial ischemia
(Sabatine et al, 2005) as well as for characterizing the
metabolic response to starvation in model organisms (Brauer
et al, 2006).
We have developed an LC-MS/MS metabolic profiling
system capable of quantifying metabolites in plasma (see
Materials and methods), and we report here its application to
studying the human response to an oral glucose load. Our
system can measure 191 endogenous human metabolites
spanning diverse chemical classes (Supplementary informa-
tion). This collection of metabolites includes those previously
studied in the context of glucose homeostasis, as well as many
metabolites not previously linked to this area. We first applied
this technology to healthy individuals to characterize the
normal human response to an oral glucose challenge, and then
asked how this response is affected by reduced insulin
sensitivity in individuals with impaired glucose tolerance.
Results
Eighteen plasma metabolites change significantly
and reproducibly during an oral glucose challenge
To systematically characterize the normal biochemical
response to glucose ingestion in humans, we obtained plasma
samples for metabolic profiling from an ongoing study,
Metabolic Abnormalities in College Students (MACS, see
Materials and methods). In this study, young adults undergo
a series of metabolic evaluations, including a questionnaire for
metabolic syndrome risk factors, indirect calorimetry, mea-
surement of body composition, and a fasting blood lipid
profile. As part of the metabolic assessment, MACS subjects
also undergo a 2-h oral glucose tolerance test (OGTT) with
multiple blood draws. To control for the fasting condition and
for the effects of fluid ingestion, a subset of MACS subjects
selected at random were given an identical volume of water
instead of the glucose solution. Venous blood was drawn
during fasting and then every 30 min following glucose or
water ingestion for the 2-h duration of the test. We obtained
samples from 22 subjects ingesting glucose and 7 control
subjects ingesting water (Table I). Serum concentrations of
glucose and insulin were measured throughout the test
(Figure 1A). All subjects had normal fasting glucose levels,
and all glucose-ingesting subjects showed normal glucose
tolerance, as currently defined by the American Diabetes
Association (2007).
We performed LC-MS/MS metabolic profiling of the OGTT
time course in MACS subjects. Out of the 191 metabolites
monitored by our platform, 97 were detected in at least 80% of
subjects in all time points (Figure 1B). The levels of 21
metabolites changed significantly (Po0.001) from the fasting
levels and were also significantly (Po0.05) different when
compared to the response to water (Figure 1C). These 21
significantly altered metabolites span pathways previously
studied in the context of glucose homeostasis, as well as some
never linked to this program.
Table I Demographic and clinical characteristics of human subjects
Clinical study MACS FOS
Group Glucosea (n=22) Waterb (n=7) FOS-NGT (n=25) FOS-IGT (n=25)
Age (years) 23±3 (18–30) 24±4 (20–30) 45±3 (40–49) 46±3 (40–50)
Gender 9 women, 13 men 3 women, 4 men 13 women, 12 men 13 women, 12 men
Ancestry Wh: 9; As: 6; Un: 7 Wh: 3; Aa: 1; As: 1; Un: 2 Wh: 25 Wh: 25
BMI 22.4±2.1 (18.3–26.9) 22.1±2.7 (17.8–26.0) 24.6±3.4 (19.0–31.5) 26.8±4.8 (18.8–41.2)
Fasting glucose (mg/100 ml) 78±5 (71–90) 77±7 (70–86) 89±6 (76–100) 100±9 (87–115)
120 min glucose (mg/100 ml) 86±16 (66–119) 80±9 (71–92) 88±21 (43–122) 153±12 (140–180)
Fasting insulin (mIU/ml) 4.6±2.9 (2.8–14.2) 3.6±0.7 (2.8–4.8) 4.2±2.7 (1.0–10.7) 10.3±8.1 (1.0–25.7)
120 min insulin (mIU/ml) 18.1±16.5 (3.0–75.9) 3.6±1.0 (2.9–5.5) 29.7±20.5 (1.0–93.3) 102.8±51.8 (35.0–202.3)
IGT/NGTc 0/22 NA 0/25 25/0
Abbreviations: MACS, Metabolic Abnormalities in College Students, conducted at MIT Clinical Research Center; FOS, Framingham Offspring Study; BMI, body mass
index. Ancestry abbreviations: Aa, African American; As, Asian; Un, unknown; Wh, White.
Quantitative variables are expressed as mean±s.d. (range).
aSubjects ingesting glucose (OGTT).
bSubjects ingesting water (control).
cNumber of subjects in each glucose tolerance category. IGT, impaired glucose tolerance (American Diabetes Association, 2007); NGT, normal glucose tolerance.
Metabolic profiling of the human response to a glucose challenge
O Shaham et al
2 Molecular Systems Biology 2008 & 2008 EMBO and Nature Publishing Group
To validate these findings, we profiled fasting and 2-h OGTT
samples from an independent cohort. The 2-h time point has
clinical significance, and can aid in the diagnosis of impaired
glucose tolerance and diabetes (American Diabetes Associa-
tion, 2007). FOS-NGT (Table I) is a group of individuals with
normal glucose tolerance, derived from the Framingham
Offspring Study (Kannel et al, 1979). This group is similar to
MACS in size, gender composition, and glucose tolerance, but
these individuals are approximately 20 years older and differ in
their ancestry (Table I). Of the 21 metabolites displaying
significant change in MACS at any time point during OGTT
(Figure 1C), the levels of 20 (glucose excluded) remained
significantly (Po0.05) altered at the 2-h time point. In total,
18 of these 20 metabolite changes replicated significantly
(Po0.05) and in the same direction in FOS-NGT (Figure 2).
The remaining two metabolites, malate and arginine, fell
below our significance threshold. We have thus identified 18
plasma metabolites exhibiting highly reproducible and likely
robust responses to glucose ingestion in healthy individuals.
Metabolic profiling reveals novel biochemical
changes during the OGTT
The systematic profiling approach has enabled us to identify a
number of plasma metabolites, not previously associated with
glucose homeostasis, that change reproducibly in response to
an oral glucose challenge. Perhaps most striking were the
observed changes in bile acids. The levels of three bile acids—
glycocholic acid, glycochenodeoxycholic acid and tauroche-
nodeoxycholic acid—more than doubled during the first
30 min after glucose ingestion, and remained elevated for the
entire 2 h (Figure 3A). Water ingestion produced a smaller
increase in bile acids, which was not sustained beyond the
30 min time point. All three compounds are primary bile acids
conjugated to glycine or taurine.
The levels of citrulline and ornithine, two non-proteinogenic
amino acids that participate in hepatic urea synthesis,
decreased by 35 and 29%, respectively during the 2-h test
(Figure 3B). Gluconeogenesis from amino acids (primarily
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Figure 1 Temporal response to an oral glucose challenge in individuals with normal glucose tolerance (MACS). (A) Kinetics of blood glucose and insulin in response to
glucose ingestion (mean±s.e.m.). (B) Magnitude and significance of metabolite change over time. Dots represent the 97 metabolites detected in plasma. Change is
with respect to the fasting metabolite levels. Significant (Po0.001) changes are colored red. (C) Significant metabolite changes. In total, 21 metabolites changed
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alanine), which supports 25–40% of the non-glycogen-derived
hepatic glucose output after an overnight fast (Felig, 1975), is
coupled to urea synthesis (Devlin, 2002). The decreases in
citrulline and ornithine may thus be associated with the
reduction in gluconeogenesis and urea synthesis following
glucose ingestion.
Hypoxanthine, a purine base generated from degradation of
adenine and guanine nucleotides, decreased in MACS by 39%
within 2 h of glucose ingestion (Figure 3C), and this pattern
was replicated in FOS-NGT. Xanthine, a purine base generated
from hypoxanthine by oxidation, also decreased in both
groups (MACS: 9%, Po0.05; FOS-NGT: 41%, Po104).
The decreases in hypoxanthine and xanthine may be explained
by a combination of attenuated release and accelerated uptake.
Hypoxanthine taken up by tissues can support nucleotide
biosynthesis through the purine salvage pathway (Mateos
et al, 1987; Yamaoka et al, 1997) and may also be indicative of
a switch from catabolism to anabolism of nucleic acids,
analogous to the simultaneous transitions in fat and protein
metabolism.
Interestingly, hippuric acid increased by over 1000% during
the first 30 min and decreased gradually thereafter. Most likely
this response is not related to glucose, but rather reflects the
presence of the preservative benzoic acid, a precursor of
hippuric acid (Kubota and Ishizaki, 1991), found in the glucose
beverage used for OGTT (see Materials and methods).
Changes in plasma metabolites span four arms
of insulin action
Much of the biochemical response to glucose ingestion, which
we studied in an unbiased way, can be attributed to the broad
actions of insulin (Figure 4A). Specifically, we have detected
an increase in lactate and decreases in glycerol, b-hydro-
xybutyrate and amino acids. These metabolite changes
correspond to the stimulation of glucose metabolism and to
the suppression of lipolysis, ketogenesis, and proteolysis (as
well as stimulation of amino-acid uptake), all of which are
0.4 0.6 0.8 1 2 3 4 5 6 7
0.4
0.6
0.8
1
2
3
4
5
6
7
MACS: 2-h fold change
FO
S-
NG
T:
 2
-h
 fo
ld
 c
ha
ng
e
Leu/Ile
Cit
Met
Val
Phe
Glycerol
Orn
Hippuric
acid
β-OH-B
Lys
Lactate
His
GCDCA
TCDCA
Pyruvate
GCA
Hypoxanthine
Tyr
Figure 2 Validation of metabolite changes at the 2-h time point. In total, 18 out
of the 20 metabolites that changed significantly in MACS (Figure 1C) replicated
(Po0.05) in FOS-NGT. Dots correspond to the median fold change of
metabolites at the 2-h time point. Abbreviations: TCDCA, taurochenodeoxycholic
acid; GCDCA, glycochenodeoxycholic acid; GCA, glycocholic acid, Orn:
ornithine, Cit: citrulline, b-OH-B: b-hydroxybutyrate.
0 30 60 90 120
–100
0
100
200
300
400
Time (min)
0 30 60 90 120
–100
0
100
200
300
400
Time (min)
0 30 60 90 120
-100
0
100
200
300
400
Time (min)
Ch
an
ge
 (%
)
TCDCA GCDCA GCA
0 30 60 90 120
–40
–20
0
20
Time (min)
0 30 60 90 120
Time (min)
Ch
an
ge
 (%
)
–40
–20
0
20
Ch
an
ge
 (%
)
Citrulline Ornithine
0 30 60 90 120
–40
–20
0
Time (min)
Ch
an
ge
 (%
)
Hypoxanthine
OGTT
Control
(water)
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known to be elicited by insulin (Fukagawa et al, 1985; Nurjhan
et al, 1986).
Our method captured the temporal relationship between
glucose and intermediates of glycolysis (Figure 4B). Specifi-
cally, the increase in pyruvate, lactate, and alanine occurred
between 30 and 60 min, lagging B30 min behind the glucose
rise, consistent with previous reports (Kelley et al, 1988).
Interestingly, the kinetics of malate, an intermediate in the
Krebs cycle, closely resembled the kinetics of lactate and
pyruvate, suggesting that a fraction of the pyruvate formed
through glycolysis was carboxylated to generate malate
through oxaloacetate. To our knowledge, elevation of plasma
malate levels due to glucose ingestion has not been previously
reported.
To gain insight into the kinetics of insulin action, we
compared temporal patterns for metabolites indicative of the
suppression of fat and protein catabolism. The levels of
glycerol, b-hydroxybutyrate, and multiple amino acids all
declined after glucose ingestion, but the kinetic pattern of
glycerol and b-hydroxybutyrate was remarkably different from
amino acids (Figure 4C). Over the 2 h, the decrease in glycerol
and b-hydroxybutyrate levels was 57 and 55%, respectively,
whereas the drop in amino acids was moderate (between 14
and 36%). The branched-chain amino acids leucine/isoleu-
cine (indistinguishable by our method), for example, de-
creased by 33%. Interestingly, the time to reach half-maximal
decrease in the amino acids (50–72 min) was greater than in
b-hydroxybutyrate (42 min) and glycerol (30 min). Moreover,
the inter-individual variance in metabolite levels shrunk
dramatically over the 2 h in glycerol and b-hydroxybutyrate
(84 and 95% reduction of inter-quartile range, respectively),
whereas in amino acids the maximal reduction was 53%.
These findings suggest that the suppression of lipolysis and
ketogenesis is more sensitive to the action of insulin compared
to suppression of protein catabolism.
Metabolite excursions reflect multiple dimensions
of insulin sensitivity
Having identified 18 metabolites that exhibit robust 2-h
excursions, we were interested in determining whether the
metabolites might be useful in understanding insulin sensi-
tivity. Insulin sensitivity is traditionally defined as the ability of
insulin to promote the uptake of glucose into peripheral tissues
such as skeletal muscle and fat or to suppress gluconeogenesis
in the liver. A decline of insulin sensitivity is one of the earliest
signs of type 2 diabetes mellitus (T2DM). This decline is often
manifest as elevated levels of fasting insulin, which is strongly
correlated with measurements of insulin sensitivity (Hanson
et al, 2000). Considering that several metabolic processes
taking place following glucose ingestion are mediated by
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insulin, we hypothesized that insulin sensitivity could be
reflected not only by changes in glucose but also by the OGTT
response of multiple other metabolites. Because our initial
studies were focused on normal, healthy individuals spanning
a narrow range of fasting insulin levels, we performed a third
analysis on a group of individuals with impaired glucose
tolerance from the Framingham Offspring Study, FOS-IGT,
who spanned a broader range of fasting insulin concentrations
(Table I).
First, to systematically evaluate the relationship between
individual metabolite excursions and fasting insulin, we
performed linear regression of the fasting insulin concentra-
tion on each of the 18 2-h excursions. Out of the 18, 6 showed
a statistically significant (Po0.05) correlation with fasting
insulin, and included the excursions in lactate, b-hydroxybu-
tyrate, amino acids (leucine/isoleucine, valine, and methio-
nine), and a bile acid (GCDCA) (Table II). Taken together with
the glycerol excursion, which scored (P¼0.07) slightly below
the significance threshold, the response of four distinct insulin
action markers correlated with fasting insulin (Figure 5A).
Individuals with high fasting insulin exhibited a blunted
excursion in all seven metabolites: they had a smaller change
both in increasing metabolites (lactate and GCDCA) and in
decreasing metabolites (the other five). Notably, the glucose
excursion was not correlated with fasting insulin (P¼0.20).
These findings suggest that resistance to the action of insulin
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Figure 5 Correlation between fasting insulin and 2-h metabolite changes in individuals with impaired glucose tolerance (FOS-IGT). (A) 2-h changes in markers of
insulin action are correlated with fasting insulin concentration. Each dot corresponds to an individual. (B) A bivariate model explaining fasting insulin using the 2-h decline
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Table II Regression models relating fasting insulin to 2-h metabolite change
in individuals with impaired glucose tolerance (FOS-IGT)
Predictor(s) R2adj P-value Prediction
errora
Db Leucine/isoleucine 0.36 9E4 6.65
D Valine 0.17 3E2 7.74
D Lactate 0.16 3E2 7.60
D Glycochenodeoxycholic acid 0.14 4E2 7.86
D Methionine 0.14 4E2 7.68
D b-Hydroxybutyrate 0.14 4E2 7.90
D Leucine/isoleucine+D glycerolc 0.54 7E5 5.66
PLSd 0.46 1E4 6.89
BMI 0.33 1E3 6.74
aThe prediction error is expressed as the root mean square error of prediction
(RMSEP), in micro-international units per milliliter insulin.
bD denotes log of the 2-h fold change of metabolite levels.
cA bivariate model consisting of the 2-h changes in leucine/isoleucine and in
glycerol.
dPartial least squares based on changes in the 18 validated metabolites.
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on the metabolism of glucose, fat, and protein is reflected by
the metabolite response to OGTT.
Next, we sought to determine whether a combination of two
or more of the 18 metabolite excursions might be more
predictive of insulin sensitivity than are individual excursions.
We used forward stepwise linear regression to discover an
optimal linear model relating 2-h metabolite changes to fasting
insulin levels. The top regression model identified consisted of
the excursions in Leu/Ile and glycerol (R2adj¼0.54, P¼0.0001).
In this bivariate model, the independent contribution from
each metabolite excursion was significant (Leu/Ile:
P¼8105, glycerol: P¼4103), and the two predictors
were not correlated with each other (P¼0.6). The Leu/Ile–
glycerol model predicted fasting insulin levels better than
any individual metabolite excursion (Table II). BMI, which is
known to be a strong predictor of fasting insulin, was less
predictive than the bivariate model. Notably, the explanatory
power of the Leu/Ile and glycerol excursions was significant
even after controlling for BMI (P¼2103 and 3103,
respectively). A graphical representation of the Leu/Ile–gly-
cerol model (Figure 5B) demonstrates that some individuals
with high fasting insulin exhibit a blunted decline in glycerol,
whereas others exhibit a blunted decline in Leu/Ile.
To identify linear combinations of all 18 metabolite
excursions that might be predictive of fasting insulin, we used
partial least squares (PLS). PLS is a multivariate method that
finds orthogonal linear combinations (called components) of
the original predictor variables (here, metabolite excursions),
which are most correlated with a response variable (here,
fasting insulin). To determine how many components should
be included in the model while keeping it general, the model is
tested on new data (a method called cross-validation). In the
current PLS model, the smallest prediction error was achieved
with the first component alone (Table II), and a similar error
was obtained with the first two components. Interestingly, the
Leu/Ile excursion had the largest coefficient in the first
component, whereas the glycerol excursion contributed
primarily to the second. The prediction error of the bivariate
model consisting of the excursions in Leu/Ile and glycerol was
lower than the PLS model error (Table II). These findings
indicate that the excursions in Leu/Ile and glycerol are
sufficient to capture the correlation of 2-h metabolite changes
with fasting insulin.
In summary, we have used a univariate approach as well as
two multivariate approaches to investigate the correlates of
insulin sensitivity. Remarkably, all three methods spotlighted
the change in Leu/Ile and change in glycerol as being
predictive of fasting insulin. Changes in these two metabolites
are blunted in insulin-resistant individuals during the OGTT.
Discussion
In the current study, we have applied metabolic profiling to
investigate the kinetics of human plasma biochemicals in
response to an oral glucose challenge. To our knowledge, this
is the first study to apply a profiling technology to characterize
this physiologic program. The systematic approach we have
taken has enabled us to recapitulate virtually all known
polar metabolite changes associated with the OGTT, while
spotlighting some pathways never linked to this program.
Importantly, simultaneous measurement of multiple metabo-
lites made it possible to explore connections among metabolic
pathways, providing novel insights into normal physiology
and disease.
One of the most surprising findings of this investigation is
the dramatic increase in bile acid levels following glucose
ingestion. In response to eating, the gallbladder contracts and
releases bile into the intestines. Bile acids are then absorbed
and travel through the portal vein back to the liver, where the
enterohepatic cycle completes. Although the uptake of bile
acids to the liver is fairly efficient, a constant fraction
(10–30%) reaches the systemic circulation (Angelin et al,
1982). In a previous investigation, human subjects ingesting a
standard liquid meal containing fat and protein exhibited an
increase of 320–330% in individual serum bile acids (De
Barros et al, 1982). In the current study, we found that
ingesting glucose alone elicits a bile acid response of similar
magnitude (Figure 3A), which is sustained for 2 h. Our finding
is supported by previous work showing that glucose ingestion
can increase the plasma concentration of cholecystokinin, a
hormone signaling the gallbladder to contract (Liddle et al,
1985). Interestingly, a recent investigation has shown that bile
acids are a signal for fat and muscle cells to increase their
energy expenditure through activation of thyroid hormone
(Watanabe et al, 2006). Given these findings, and our
observation of bile acid release following glucose ingestion,
we tested the hypothesis that bile acids influence peripheral
glucose uptake. We could not detect an effect of bile acids on
basal or insulin-stimulated glucose uptake, however, in
cultured adipocytes (data not shown). At present, the
physiologic role of sustained bile acid release following
glucose ingestion is unknown.
Although insulin resistance is traditionally defined as the
reduced ability of insulin to promote glucose uptake or as the
impaired suppression of gluconeogenesis, resistance can
emerge in other insulin-dependent processes. In prior studies,
for example, inadequate suppression of lipolysis was observed
in women with a history of gestational diabetes (Chan et al,
1992), and an elevated proteolysis rate was seen in individuals
with HIV-associated insulin resistance (Reeds et al, 2006). In
obesity, manifestations of insulin resistance include elevated
rates of lipolysis (Robertson et al, 1991) and proteolysis
(Jensen and Haymond, 1991; Luzi et al, 1996). We have used
metabolic profiling to monitor insulin action across multiple
axes (Figure 4A), and with markers of each axis in hand, were
able to detect kinetic differences between them. In healthy
individuals, insulin’s suppression of lipolysis and ketogenesis
is rapid compared to its suppression of proteolysis (Figure 4C),
consistent with the different concentrations of insulin required
to inhibit each of these processes (Fukagawa et al, 1985;
Nurjhan et al, 1986). Such differences in the activation
thresholds of metabolic pathways could be contributing to
the diversity in the clinical presentation of insulin resistance.
Mouse models of insulin-resistant T2DM provide another
example for inter-pathway differences in insulin sensitivity: in
the livers of these mice, gluconeogenesis is resistant to
suppression by insulin, whereas lipogenesis is responsive,
resulting in hyperglycemia and hypertriglyceridemia (Brown
and Goldstein, 2008). Collectively, these observations
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demonstrate that environmental or genetic perturbations
could lead to selectivity in insulin sensitivity and contribute
to pathogenesis.
Our study demonstrates that an individual’s ‘insulin
response profile’, namely, the vector of sensitivities to insulin
action along multiple physiologic axes, can be revealed by
metabolite excursions in response to a glucose challenge.
Specifically, we have shown that excursions in Leu/Ile and
glycerol, reflecting the sensitivity of proteolysis and lipolysis to
the action of insulin, are jointly predictive of fasting insulin,
with each of the two excursions offering complementary and
significant explanatory power (Figure 5B). These findings
demonstrate that in two individuals, different axes could be
responsible for the same elevation of fasting insulin, and
simultaneous measurement of metabolites can distinguish
between the two conditions. Monitoring the response to
glucose ingestion across multiple axes in larger, prospective
clinical studies of pre-diabetics could establish links between
insulin sensitivity profiles and disease progression, thus
helping to predict future diabetes and its complications as
well as to guide therapeutic interventions.
Materials and methods
Human subjects
MACS
Subjects were young adults in the age range of 18–30 years who
volunteered for the study during the academic year 2006–2007. Control
subjects (ingesting water instead of glucose solution) were assigned at
random, balancing gender. Metabolic profiling analysis was limited to
those subjects with normal fasting glucose concentrations (below
100 mg/100 ml) and normal glucose tolerance (2-h glucose concentra-
tion below 140 mg/100 ml).
FOS
Subjects were selected at random (balancing gender) from among all
participants in the fifth FOS examination cycle (1991–1995) aged 40–
49 years who had no diabetes mellitus, hypertension or prior
cardiovascular disease. Additional selection criteria for FOS-NGTwere
normal fasting glucose concentrations and normal glucose tolerance.
Additional selection criterion for FOS-IGT was impaired glucose
tolerance (2-h glucose concentration between 140 and 199 mg/
100 ml).
Table I lists demographic and metabolic characteristics of cohorts
from the MACS and FOS studies.
OGTT
MACS
Subjects were admitted to the Massachusetts Institute of Technology
Clinical Research Center (CRC) after a 10 h overnight fast. An
intravenous catheter was inserted into an antecubital vein or a wrist
vein and fasting samples were drawn. Next, each subject ingested a
glucose solution (Trutol, 75 g in 296 ml; NERL Diagnostics, East
Providence, RI; contains citric acid and sodium benzoate) or an
identical volume of bottled water (Poland Spring Water, Wilkes Barre,
PA) over a 5-min period. Additional blood samples were drawn from
the inserted catheter 30, 60, 90 and 120 min after ingestion. Subjects
remained at rest throughout the test. The study protocol was approved
by the MIT Committee on the Use of Humans as Experimental Subjects
and the CRC Scientific Advisory Committee.
FOS
Subjects underwent an OGTT as part of the FOS (Arnlov et al, 2005).
After 12 h overnight fast, subjects ingested 75 g glucose in solution.
Blood samples were drawn fasting and 120 min after glucose ingestion.
The study protocol was approved by the Institutional Review Board at
Boston Medical Center.
Metabolic profiling
Blood processing
Blood was drawn into EDTA-coated tubes. In MACS, blood was
centrifuged for 10 min at 61C and 2000 g. In FOS, blood was centrifuged
for 30 min at 41C and 1950 g. Plasma samples were stored at 801C.
Sample preparation and analysis
Plasma samples were thawed gradually, and 165ml from each sample
was mixed with 250 ml of ethanol solution (80% ethanol, 19.9% H2O,
and 0.1% formic acid) to precipitate out proteins. After 2 h at 41C, the
samples were centrifuged at 15 000 g for 15 min, and 300 ml of the
supernatant was extracted and evaporated under nitrogen. Samples
were reconstituted in 60ml HPLC-grade water, and separated on three
different HPLC columns. The columns were connected in parallel to a
triple quadrupole mass spectrometer (4000 Q Trap; Applied Biosys-
tems) operated in selected reaction-monitoring mode. Each metabolite
was identified by a combination of chromatographic retention time,
precursor ion mass, and product ion mass. Metabolite quantification
was performed by integrating the peak areas of product ions using
MultiQuant software (Applied Biosystems). Additional details on
the analytical methodology are provided in the Supplementary
information.
Glucose and insulin
Plasma glucose concentration was measured with a hexokinase assay
(MACS: Quest Diagnostics, Cambridge, MA; FOS: Abbott Laboratories,
IL). Insulin international units were determined using a radio-
immunoassay (Diagnostic Product Corporation, Los Angeles, CA). In
MACS, sodium fluoride–potassium oxalate blood tubes were used for
glucose analysis, and blood tubes with no additive were used for
insulin analysis.
Statistical analysis
Univariate analysis
The significance of a change from the fasting metabolite level was
calculated using the paired Wilcoxon signed-rank test. The signifi-
cance of a difference between glucose and water ingestion was
calculated using the unpaired Wilcoxon rank sum test. Where allB100
detected metabolites were tested, a significance threshold of a¼0.001
was used to account for multiple hypotheses testing. A threshold of
a¼0.05 was used elsewhere.
Multivariate analysis and linear regression
Two multivariate approaches were used to identify combinations of
2-h metabolite changes predictive of fasting insulin: forward stepwise
linear regression and PLS regression. In stepwise linear regression, the
significance threshold for addition of a variable to the model was
a¼0.05. In PLS regression, the number of components to include in the
model was determined using leave-one-out cross-validation. The
prediction error of a model was expressed as the root mean square
error of prediction. Missing values (less than 2% of the data) were
replaced with the mean of present values.
Statistical analysis was performed in R (The R Project for Statistical
Computing) and in Matlab (The MathWorks Inc.).
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Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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